Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

Douglas Adkins; Jessica Ley; Prakash Neupane; Francis Worden; Assuntina G. Sacco; Kevin Palka; Juneko E. Grilley-Olson; Ronald Maggiore; Noha N. Salama; Kathryn Trinkaus; Brian A. Van Tine; Conor E. Steuer; Nabil F. Saba; Peter Oppelt

doi:10.1016/S1470-2045(19)30405-X

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

Douglas Adkins
, Jessica Ley
, Prakash Neupane
, Francis Worden
, Assuntina G. Sacco
, Kevin Palka
, Juneko E. Grilley-Olson
, Ronald Maggiore
, Noha N. Salama
, Kathryn Trinkaus
, Brian A. Van Tine
, Conor E. Steuer
, Nabil F. Saba
, Peter Oppelt

Pharmaceutical and Administrative Sciences Department

Washington University School of Medicine in St. Louis
Washington University in Saint Louis School of Medicine
University of Kansas School of Medicine
University of Michigan Medical School
University of California San Diego
Saint Louis University School of Medicine
University of North Carolina School of Medicine
University of Rochester Medical Center
Cairo University Faculty of Pharmacy
Emory University

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1295-1305
Number of pages	11
Journal	The Lancet Oncology
Volume	20
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(19)30405-X
State	Published - Sep 2019

ASJC Scopus Subject Areas

Oncology

Access to Document

10.1016/S1470-2045(19)30405-X

Cite this

Adkins, D., Ley, J., Neupane, P., Worden, F., Sacco, A. G., Palka, K., Grilley-Olson, J. E., Maggiore, R., Salama, N. N., Trinkaus, K., Van Tine, B. A., Steuer, C. E., Saba, N. F., & Oppelt, P. (2019). Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial. The Lancet Oncology, 20(9), 1295-1305. https://doi.org/10.1016/S1470-2045(19)30405-X

Adkins, D, Ley, J, Neupane, P, Worden, F, Sacco, AG, Palka, K, Grilley-Olson, JE, Maggiore, R, Salama, NN, Trinkaus, K, Van Tine, BA, Steuer, CE, Saba, NF & Oppelt, P 2019, 'Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial', The Lancet Oncology, vol. 20, no. 9, pp. 1295-1305. https://doi.org/10.1016/S1470-2045(19)30405-X

@article{69617adba9c24f9898b5f65cefae0e13,

title = "Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial",

author = "Douglas Adkins and Jessica Ley and Prakash Neupane and Francis Worden and Sacco, \{Assuntina G.\} and Kevin Palka and Grilley-Olson, \{Juneko E.\} and Ronald Maggiore and Salama, \{Noha N.\} and Kathryn Trinkaus and \{Van Tine\}, \{Brian A.\} and Steuer, \{Conor E.\} and Saba, \{Nabil F.\} and Peter Oppelt",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Ltd",

year = "2019",

month = sep,

doi = "10.1016/S1470-2045(19)30405-X",

language = "English",

volume = "20",

pages = "1295--1305",

journal = "The Lancet Oncology",

issn = "1470-2045",

number = "9",

}

TY - JOUR

T1 - Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer

T2 - a multicentre, multigroup, phase 2 trial

AU - Adkins, Douglas

AU - Ley, Jessica

AU - Neupane, Prakash

AU - Worden, Francis

AU - Sacco, Assuntina G.

AU - Palka, Kevin

AU - Grilley-Olson, Juneko E.

AU - Maggiore, Ronald

AU - Salama, Noha N.

AU - Trinkaus, Kathryn

AU - Van Tine, Brian A.

AU - Steuer, Conor E.

AU - Saba, Nabil F.

AU - Oppelt, Peter

PY - 2019/9

Y1 - 2019/9

UR - https://www.scopus.com/pages/publications/85071533195

UR - https://www.scopus.com/pages/publications/85071533195#tab=citedBy

U2 - 10.1016/S1470-2045(19)30405-X

DO - 10.1016/S1470-2045(19)30405-X

M3 - Article

C2 - 31351869

AN - SCOPUS:85071533195

SN - 1470-2045

VL - 20

SP - 1295

EP - 1305

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 9

ER -

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this